ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 13 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $19,975,000 | – | 13,841,000 | – | 2.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 16,800,000 | $22,837,000 | 2.09% |
| Redmile Group, LLC | 19,000,000 | $25,656,000 | 1.56% |
| CSS LLC/IL | 17,405,000 | $23,518,000 | 1.14% |
| LINDEN ADVISORS LP | 16,335,000 | $22,249,000 | 0.94% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,715,000 | $28,081,000 | 0.36% |
| Fernwood Investment Management, LLC | 90,000 | $122,000 | 0.09% |
| Baker Brothers Advisors | 3,000,000 | $4,066,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 13,500,000 | $18,385,000 | 0.04% |
| Citadel Advisors | 22,070,000 | $29,896,000 | 0.02% |
| GABELLI FUNDS LLC | 1,501,000 | $2,037,000 | 0.01% |